Addressing Medtech RWE Challenges With Connected RWD
Written by
Tasha Boshears
Senior Director, Commercial Analytics
Quick Navigation
A billing code can show that a procedure happened, but it can’t detail what occurred in the operating room, what approach the surgeon took, or what the outcomes were. For medtech real-world evidence (RWE) teams, that context makes all the difference. It’s why manufacturers have invested time and resources into manual chart extraction, primary data collection, and hospital chargemaster datasets. For many years, medtech RWE teams have been left to piece together the additional context they need to understand outcomes, utilizations, and costs.
Now, real-world data (RWD) sources are increasingly linked to inform pre-launch and post-commercial initiatives. There’s a growing use of RWD linkage across U.S. clinical trials, and the FDA recently announced updated guidance regarding medtech RWE, naming electronic health records (EHRs), medical claims, and registries as acceptable RWD sources.
This is just the start of a key shift in medtech development: more connected data is helping manufacturers better understand where their patients are and what their care journeys look like. Linked datasets are replacing traditional RWE methods, retaining visibility into complete patient journeys while allowing manufacturers to move faster, answer tougher questions, and still meet regulatory requirements.
This blog explores the most common challenges of traditional medtech RWE, and how increasingly linked data is advancing evidence generation capabilities.
Common medtech RWE challenges
Meaningful device details are documented in the EHR record of a procedure. They live in clinical notes and EHR data, providing context about the techniques and tools used to implant a device and whether or not there was a complication.
To make up for this gap from closed claims, medtech RWE teams have used the following methods – manual, time-consuming steps to fill in important details.
- Manual chart abstraction. This requires selecting sites, having an abstraction expert and reviewer present, and only allows teams to pull a limited number of charts. Even a well-run effort can only gather so much information, which minimizes sample sizes and extends project timelines.
- Primary data collection. Rather than pulling data from charts after a procedure, primary data collection occurs in the moment. It requires multiple sites and multiple auditors overviewing a surgery. Each auditor must be trained, and every auditor group requires interobserver reliability tracking so the findings hold up, an additional layer of coordination and costs.
- Chargemaster data. Medtech RWE teams have long been reliant on hospital chargemaster data for secondary RWD – but this was built for billing. It has critical gaps to the full clinical context. Chargemaster data doesn’t tell the story around the procedure, such as:
- Unique device identifier (UDI) capture, matched against the FDA Global Unique Device Identification Database (GUDID).
- Reusable tools (such as bone cutting tools) don’t show up at all since they are not billed.
- Procedure codes such as ICD-10-PCS and Current Procedural Terminology (CPT) rarely describe the operative technique.
- Complications and observations during surgery often never make it into billing codes.
These methods have been the best substitute for RWD up until now. They’ve allowed medtech RWE teams to identify when procedures happened, and if investing in primary data collection, to understand how those operations went. However, each has a significant cost in time added to a project and investment in staff and data pulls.
How connected data is building stronger evidence faster
Fortunately, the data needed to build a strong medtech RWE case has become easier to access. EHR data adds detail beyond the chargemaster, sharing context from the operating room via the operative note. This adds the detail that billing codes can’t, including:
- Incision timestamps. These provide deeper clinical context beyond operative time, which is typically based on scheduling data versus the actual surgical time. Incision and closing times show how long surgery actually took, giving teams a much sharper way to compare techniques or track a learning curve.
- The tools behind the device. The note shows how a device went in, whether that was a bone cutting tool, a laser, an electric saw, or a chisel and hammer. Tools can influence outcomes; they’re a key detail beyond the device itself.
- How the patient responded. Did blood pressure dip? Did heart rate change, a fever start, or oxygen drop? Was there a nicked nerve? Did the patient receive perioperative antibiotics or a blood transfusion? This detail is critical for patient safety; it helps reduce future adverse events and make a case for effectiveness.
After a device is implanted, post-operative notes extend the clinical context further, allowing sponsors to see if patients spiked a fever, acquired an infection, or experienced other complications while under continued monitoring. Post-operative notes also include important progression characteristics: has the bone fused, has the incision healed, have pain scores decreased?
When connected with claims data, medtech teams get a more complete patient picture. They can see what happened in the operating room with clear detail beyond billing data and follow patients after discharge, getting visibility to payer transitions, downstream utilizations and additional interventions, and cost of care.
Building evidence for every stage of the device lifecycle
For pre-launch teams, connected RWD across claims, EHR, and clinical notes provide a detailed look at the intended-use population, ground endpoints and comparators in real-world standard-of-care outcomes, trial feasibility, and sites with the right procedure volume. For post-commercial teams, more complete data informs how devices compare to competitors, impact outcomes and costs, and follows patients after the device is implanted.
Medtech RWE teams can now see the full impact of a device, from the point of care to years of outcomes – all informed by more complete RWD. Inform your next project with data that details the full patient journey with real-world data for medical devices.